Christopher Krueger - 02 Jan 2024 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Chief Business Officer
Signature
/s/ Christopher Krueger
Issuer symbol
VTYX
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
4
Filing time
03 Jan 2024, 18:19:04 UTC
Previous filing
21 Dec 2023
Next filing
29 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTYX Stock Option (Right to Buy) Award $0 +125,000 $0.000000 125,000 02 Jan 2024 Common Stock 125,000 $2.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the total shares subject to the Option shall vest on the one-year anniversary of January 2, 2024, subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2021 Equity Incentive Plan) through such date.